- Home
- UEIC vs PROK Comparison
UEIC vs PROK Comparison
Compare UEIC & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEIC
- PROK
- Stock Information
- Founded
- UEIC 1986
- PROK 2015
- Country
- UEIC United States
- PROK United States
- Employees
- UEIC N/A
- PROK N/A
- Industry
- UEIC Consumer Electronics/Appliances
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UEIC Consumer Staples
- PROK Health Care
- Exchange
- UEIC Nasdaq
- PROK Nasdaq
- Market Cap
- UEIC 79.4M
- PROK 126.8M
- IPO Year
- UEIC 1993
- PROK N/A
- Fundamental
- Price
- UEIC $6.16
- PROK $0.91
- Analyst Decision
- UEIC Strong Buy
- PROK Buy
- Analyst Count
- UEIC 2
- PROK 4
- Target Price
- UEIC $14.50
- PROK $5.00
- AVG Volume (30 Days)
- UEIC 89.7K
- PROK 559.6K
- Earning Date
- UEIC 05-01-2025
- PROK 03-17-2025
- Dividend Yield
- UEIC N/A
- PROK N/A
- EPS Growth
- UEIC N/A
- PROK N/A
- EPS
- UEIC N/A
- PROK N/A
- Revenue
- UEIC $394,879,000.00
- PROK $76,000.00
- Revenue This Year
- UEIC $3.65
- PROK N/A
- Revenue Next Year
- UEIC $9.05
- PROK N/A
- P/E Ratio
- UEIC N/A
- PROK N/A
- Revenue Growth
- UEIC N/A
- PROK N/A
- 52 Week Low
- UEIC $6.10
- PROK $0.87
- 52 Week High
- UEIC $14.20
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- UEIC 26.50
- PROK 32.38
- Support Level
- UEIC $6.44
- PROK $0.87
- Resistance Level
- UEIC $6.96
- PROK $1.06
- Average True Range (ATR)
- UEIC 0.34
- PROK 0.10
- MACD
- UEIC 0.05
- PROK 0.01
- Stochastic Oscillator
- UEIC 5.17
- PROK 21.95
About UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.